Nicotine-mecamylamine treatment for smoking cessation: The role of pre-cessation therapy.

Rose, Jed E., Behm, Frederique M., Westman, Eric C.·1998·Experimental and Clinical Psychopharmacology

Cited by (21)

  1. Nicotine replacement therapy for smoking cessation
    Stead, Lindsay F, Perera, Rafael, Bullen, Chris, Mant, David, Hartmann-Boyce, Jamie, Cahill, Kate, Lancaster, Tim · 2012 · Cochrane Database of Systematic Reviews
  2. Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
    Gonzales, David · 2006 · JAMA
  3. Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation
    Coe, Jotham W., Brooks, Paige R., Vetelino, Michael G., Wirtz, Michael C., Arnold, Eric P., Huang, Jianhua, Sands, Steven B., Davis, Thomas I., Lebel, Lorraine A., Fox, Carol B. et al. · 2005 · Journal of Medicinal Chemistry
  4. Nicotine replacement therapy for smoking cessation
    Stead, Lindsay F, Perera, Rafael, Bullen, Chris, Mant, David, Lancaster, Tim · 2008 · Cochrane Database of Systematic Reviews
  5. Applying extinction research and theory to cue‐exposure addiction treatments
    Conklin, Cynthia A., Tiffany, Stephen T. · 2002 · Addiction
  6. Rationale, pharmacology and clinical efficacy of partial agonists of α4β2 nACh receptors for smoking cessation
    Rollema, Hans, Coe, Jotham W., Chambers, Leslie K., Hurst, Raymond S., Stahl, Stephen M., Williams, Kathryn E. · 2007 · Trends in Pharmacological Sciences
  7. Smoking Cessation With Varenicline, a Selective α4β2 Nicotinic Receptor Partial Agonist: Results From a 7-Week, Randomized, Placebo- and Bupropion-Controlled Trial With 1-Year Follow-up
    Nides, Mitchell · 2006 · Archives of Internal Medicine
  8. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation
    Oncken, Cheryl · 2006 · Archives of Internal Medicine
  9. Nicotine and nonnicotine factors in cigarette addiction
    Rose, Jed E. · 2006 · Psychopharmacology
  10. Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial
    Aubin, H-J, Bobak, A, Britton, J R, Oncken, C, Billing, C B, Gong, J, Williams, K E, Reeves, K R · 2008 · Thorax
  11. Us Public Health Service Clinical Practice Guideline: Treating Tobacco Use and Dependence
    Fiore, Michael C, Guideline Panel and Staff · 2000 · Respiratory Care
  12. Interventions for preventing weight gain after smoking cessation
    Farley, Amanda C, Hajek, Peter, Lycett, Deborah, Aveyard, Paul · 2012 · Cochrane Database of Systematic Reviews
  13. Nicotinic acetylcholine receptors as targets for antidepressants
    Shytle, R D, Silver, A A, Lukas, R J, Newman, M B, Sheehan, D V, Sanberg, P R · 2002 · Molecular Psychiatry
  14. Analysis of Mecamylamine Stereoisomers on Human Nicotinic Receptor Subtypes
    Papke, Roger L., Sanberg, Paul R., Shytle, R. Douglas · 2001 · The Journal of Pharmacology and Experimental Therapeutics
  15. Monoamine transporters and psychostimulant addiction
    Howell, Leonard L., Kimmel, Heather L. · 2008 · Biochemical Pharmacology
  16. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation
    Lindson, Nicola, Chepkin, Samantha C, Ye, Weiyu, Fanshawe, Thomas R, Bullen, Chris, Hartmann-Boyce, Jamie · 2019 · Cochrane Database of Systematic Reviews
  17. Nicotine Replacement Therapy : An Overview
    Wadgave, Umesh, L., Nagesh · 2016 · International Journal of Health Sciences
  18. Mecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders
    Bacher, Ingrid, Wu, Becky, Shytle, Douglas R, George, Tony P · 2009 · Expert Opinion on Pharmacotherapy
  19. Nicotine patch therapy prior to quitting smoking: a meta‐analysis
    Shiffman, Saul, Ferguson, Stuart G. · 2008 · Addiction
  20. Effects of sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats
    Rezvani, Amir H., Slade, Susan, Wells, Cori, Petro, Ann, Lumeng, Lawrence, Li, Ting-Kai, Xiao, Yingxian, Brown, Milton L., Paige, Mikell A., McDowell, Brian E. et al. · 2010 · Psychopharmacology
  21. Comorbid bipolar disorder in Tourette’s syndrome responds to the nicotinic receptor antagonist mecamylamine (Inversine)
    Shytle, R.Douglas, Silver, Archie A, Sanberg, Paul R · 2000 · Biological Psychiatry

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.